Clinical Trial Update: Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF) [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing intravenous branched-chain amino acids for hepatic encephalopathy in patients with acute-on-chronic liver failure has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy
• On Chronic Liver Failure

Drugs mentioned

• Intravenous Branched-Chain Amino Acids (branched-chain amino acids)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Hepatic Encephalopathy, Acute-On-Chronic Liver Failure | Phase 1 | Status: COMPLETED